Wednesday, 24 May 2017

India News

  • Wockhardt increases investment in R&D

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Addressing shareholders in the company's annual report, Indian drugmaker Wockhardt said that the company plans to further strengthen its research and development capabilities and...Read more

  • Eli Lilly's corporate social responsibility impact

    India |  Opinion | By BioSpectrum Bureau | 0 Comment

    For more than 135 years, Eli Lilly and Company has demonstrated a commitment to be a responsible global citizen, in large part, through a long history of philanthropic contributions. Our gr...Read more

  • Europe plants €3.7 billion in bio-based economy

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: European Commission president Mr José Manuel Barroso, and Commissioner for Research, Innovation and Science, Ms Máire Geoghegan-Quinn, announced the formal launch of a â...Read more

  • Glenmark bags FDA approval for skin ointment

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Triamcinolone Acetonide Ointment USP...Read more

  • Lupin gets FDA nod for generic Ortho Tri-cyclen Lo Tablets

    India |  Regulatory | By BioSpectrum Bureau | 0 Comment

    Mumbai: Mumbai-based pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received approval for its Norgestimate and Ethinyl Estradiol Tablets, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, a...Read more

  • Lupin inks strategic JV agreement with Yoshindo

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Pharma Major, Lupin Limited announced today that it has entered into a strategic joint venture agreement with Toyama based Japanese pharmaceuticals company, Yoshindo Inc. (Yoshin...Read more

  • Ten top Indian life science collaborations of 2012

    India |  Analysis | By Vipul Murarka | 0 Comment

    As the market for new drugs evolves, the methodologies for moving them into the market is changing and becoming more complex. Companies are increasingly relying on efficient collaboration s...Read more

  • APAC multiple myeloma market to value $2.8 bn by 2021: Report

    India |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, and Australia will rise in value from USD1.7 billion in 2014 to USD2.8 ...Read more

  • India slashes prices of 54 essential drugs

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: With a view to make medicines for critical diseases more affordable, India's National Pharmaceutical Pricing Authority ( NPPA ) has slashed prices of 54 essential medicines by up...Read more

  • Baxter erects global R&D center at Syngene

    India |  News | By BioSpectrum Bureau | 0 Comment

    Bangalore: Baxter has constructed its R&D center at Biocon's Syngene facility. The facility, which was developed as a collaborative effort between the two organizations, has been name...Read more

  • India's Biological E to buy French Valneva's CMO unit

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: France-based biotech firm Valneva is selling its clinical manufacturing operations (CMO) in Nantes to India-based Biological E. The sale of this unit, which is dedicated to the ...Read more

  • Lupin gets 16 FDA nods, launches 11 products front

    India |  Analysis | By Amrita Tejasvi | 0 Comment

    US remained an unstirred focus for Indian pharmaceutical company Lupin as it went on achieving 16 approvals from US FDA and launched 11 products during 2012. Besides building a strong gri...Read more

  • FDA approves Sun Pharma's generic Prandin

    India |  Regulatory | By BioSpectrum Bureau | 0 Comment

    Singapore: The US Food and Drug Administration (FDA) has given its finally approval to India's Sun Pharmaceutical Industries for releasing its diabetes generic Prandin. Making the announce...Read more

  • Singapore's Fortis Surgical Hospital is now Concord Medical Services

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Concord Medical Services, China based hospital management solution provider, has received Singapore's approval to change the name of the Fortis Surgical Hospital, which was acqui...Read more

  • Cipla, Alembic contest Indian drug pricing in court

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Miffed at Indian government's move to slash prices of essential medicines through the new drug pricing policy, drug makers Cipla and Alembic have now moved court. The Indian gov...Read more

  • India's AYUSH becomes popular in Asia

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: With the ancient Indian medicine systems AYUSH (Ayurveda, Yoga, Unani, Siddha and Homeopathy) gaining popularity in Asian countries, the Ministry of AYUSH is receiving requests t...Read more

  • Quintiles and Biogen Idec ink pact

    India |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Quintiles and US-based biotech company Biogen Idec have entered into a five-year strategic clinical development agreement. The multi-year collaboration is designed to leverage t...Read more

  • Biocon launches world's first Biosimilar 'CANMAb' in India

    India |  News | By BioSpectrum Bureau | 0 Comment

    Bangalore: CANMAb has been jointly developed by Biocon in partnership with Mylan and it is said to be the world's first biosimilar version of Herceptin. At the launch this morning, Dr Kira...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls